Skip to main content
Premium Trial:

Request an Annual Quote

Michael Milburn, Gideon Shapiro, Gary Alianell.

Premium

Structural GenomiX, based in San Diego, Calif., has appointed Michael Milburn vice president of structural biology.

Prior to joining Structural GenomiX, Milburn established the structure-based X-ray crystallography and computational chemistry groups at Glaxo Wellcome, where he was responsible for coordinating the informatics needs of the research organization in developing and implementing computational tools.

Gideon Shapiro, CEO and president of EraGen Biosciences of Alachua, Fla., is stepping down in order to pursue other activities, the company said.

Shapiro will continue with the company to assist with its business development and financing and will also remain on the board of directors “for the foreseeable future,” he said.

EraGen did not say who would replace Shapiro. Gary Alianell, formerly president of NucleoTech, has been appointed COO.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.